Tamás Henics, MD, PhD
Co-Founder and Chief Scientific Officer
Tamás Henics has decades long experience in research leadership in academic and biotechnology setting. Dr. Henics received his MD degree in Hungary in 1990 and a PhD degree in molecular immunology and cell biology in 1996.
Henics worked in several academic institutes in the US (Dartmouth College and Medical School, Hanover, NH; Roswell Park Cancer Institute, Buffalo, NY) and in Hungary (Dept. of Medical Microbiology and Immunology, Medical University of Pécs) before he joined Intercell (Vienna, Austria) in 1999. He had a major contribution to the development of the bacterial antigen discovery platform and antimicrobial peptide based vaccine adjuvants. From 2005 he continued his research activity on adjuvants in the Dept. of Genetics at the Marx F. Perutz Laboratories in Vienna and supported the understanding of mode of action of synthetic vaccine adjuvant developed by Intercell. In 2010 he joined the RT-EUROPE Research Laboratories in Hungary as Head of Research, where he worked until the foundation of EveliQure. Dr. Henics published his research work in > 40 peer-reviewed research journals in the last 12 years mainly in vaccination related topics and he is inventor on several patents.